Sphingosine kinase inhibitors

Details for Australian Patent Application No. 2006261327 (hide)

Owner Apogee Biotechnology Corporation

Inventors Zhuang, Yan; French, Kevin J.; Smith, Charles D.

Agent Spruson & Ferguson

Pub. Number AU-B-2006261327

PCT Pub. Number WO2006/138660

Priority 60/691,563 17.06.05 US

Filing date 15 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 5 July 2012

International Classifications

C07C 323/25 Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07C 233/49 Carboxylic acid amides

C07C 233/59 Carboxylic acid amides

C07C 233/60 Carboxylic acid amides

C07C 233/62 Carboxylic acid amides

C07C 255/44 Carboxylic acid nitriles

C07C 317/32 Sulfones

C07C 323/32 Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 207/26 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 263/58 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/46 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/82 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 317/58 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138660 Priority application(s): WO2006/138660

5 July 2012 Application Accepted

  Published as AU-B-2006261327

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261335-Methods for treating dermatitis using mutant human IL-4 compositions

2006261325-Permeant delivery system and methods for use thereof